Let’s leverage AI to make Americans healthier.
As policymakers navigate the challenges of incorporating AI into life sciences and healthcare, it's crucial to acknowledge the existing regulatory frameworks governing AI's use in these areas.
When updates are necessary, it is vital for policymakers to collaborate with industry to ensure new regulations act as a catalyst for innovation, not a barrier.
This approach ensures we can maintain a dynamic and competitive market.
Read more from the a16z Bio + Health team (Colin Rom, Jay Rughani, Vijay Pande, PhD, Jeff Clark) on the 3 things regulators should do to prepare for the AI revolution in bio and health: https://lnkd.in/gxCC3iXt
🇦🇴🇦🇴🇦🇴🖤💜🖤💜🖤💜🖤💜